ArticleRMD open2019

Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible.

Olafur Palsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.